Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10017
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic anhydrase 2
- Cytochrome P450 19A1
- Steryl-sulfatase
| - (4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl) sulfamate
- JMC503540 Compound 2
- YM511 Analog 4
- YM511-based dual aromatase-sulfatase inhibitor (DASI) 4
- dual aromatase-sulfatase inhibitor 4
|
BDBM10020
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic anhydrase 2
- Cytochrome P450 19A1
- Steryl-sulfatase
| - (2-bromo-4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl) sulfamate
- JMC503540 Compound 5
- YM511 Analog 5
- YM511-based dual aromatase-sulfatase inhibitor (DASI) 7
- dual aromatase-sulfatase inhibitor 7
|
BDBM10297
 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-2
- Caspase-3
- Caspase-4
- Caspase-6
- Caspase-7
- Caspase-8
- Caspase-9
| - 1-methyl-5-nitro-2,3-dihydro-1H-indole-2,3-dione
- Isatin analog 1
|
BDBM10298
 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-2
- Caspase-3
- Caspase-4
- Caspase-6
- Caspase-7
- Caspase-8
- Caspase-9
| - 1-benzyl-5-nitro-2,3-dihydro-1H-indole-2,3-dione
- Isatin analog 2
|
BDBM10304
 | 6 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Acyl-CoA: cholesterol acyltransferase (ACAT)
- Carboxylesterase 1
- Caspase-3
- Cholinesterases
- Chorismate mutase (MTB CM)
- Factor XIIa
- Human rhinovirus A protease
- Transthyretin
| - 1-methyl-2,3-dihydro-1H-indole-2,3-dione
- CHEMBL60569
- Isatin analog 8
- N‐methylindol‐2,3‐dione (Compound 2)
|
BDBM10316
 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-2
- Caspase-3
- Caspase-4
- Caspase-6
- Caspase-7
- Caspase-8
- Caspase-9
| - (R)-5-{1-[2-(Anilinomethyl)pyrrolidinyl]sulfonyl}isatin
- 5-{[(2R)-2-[(phenylamino)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Isatin Sulfonamide 27
|
BDBM10348
 | 1 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 5-(2-(Pyridin-3-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 5-{[(2S)-2-[(pyridin-3-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- IST-1
- Pyridine Analogue 20
|
BDBM103534
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - CHEMBL474152
- US10201527, Compound 40
- US10736881, Compound 14
- US8551988, 14
|
BDBM103776
 | 6 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | - Beta-2 adrenergic receptor
- Muscarinic acetylcholine receptor M3
| - US8551978, I-46
- US8816088, I-46
- US9394275, I-46
- US9572802, Compound I-46
- US9682957, I-46
|
BDBM104175
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Serine/threonine-protein kinase PIM-3
- Serine/threonine-protein kinase pim-1
- Serine/threonine-protein kinase pim-2
| - US8575145, 157
- US8575145, 158
- US8575145, 52/127/128
|
BDBM106698
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine 1D receptor (5HT1D)
- Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Nitric-oxide synthase, brain
- Serotonin 1B/1D receptor
| - CHEMBL1957349
- US8586620, 42
|
BDBM107656
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - 11-beta-hydroxysteroid dehydrogenase
- 11-beta-hydroxysteroid dehydrogenase 1
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 3A
| |
BDBM107703
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Prolyl hydroxylase EGLN3
| - US10889546, US2007/0299086 Table 2.4
- US8598210, Table XV, 9
- US8722895, 9: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid
- US9598370, Example 00134
- USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid
|
BDBM108095
 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Coagulation factor XI
- Complement C1r subcomponent
- Complement C1s
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| |
BDBM108097
 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Coagulation factor XI
- Complement C1r subcomponent
- Complement C1s
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| |
BDBM108112
 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Coagulation factor XI
- Complement C1r subcomponent
- Complement C1s
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| |
BDBM10841
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual specificty protein kinase CLK1
- Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
- Glycogen Synthase Kinase-3, beta
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
| - 4-(6-bromo-1H-indol-3-yl)pyrimidin-2-amine
- Meridianin D
|
BDBM108464
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Glutaminase kidney isoform, mitochondrial
- Glutaminase liver isoform, mitochondrial
| - US8604016, 21
- US9938267, Cmpd ID 21
|
BDBM10960
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Butyrylcholinesterase
- Cholinesterases
| - (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-[4-(propan-2-yl)phenyl]carbamate
- 4-isopropylphenserine
- Cymserine
- cymserine.tartaric acid
|
BDBM10984
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Cholinesterases
| - (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N,N-dimethylcarbamate
- CHEMBL308043
- N-methylphysostigmine
- Physostigmine analog 33
|
BDBM109863
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
| - US8609647, 1
- US8609647, 15
- US8609647, 2
- US8609647, 23
|
BDBM11018
 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase type B (MAO-B) Mutant (I199F)
| - 2-[(E)-2-(3-chlorophenyl)ethenyl]-3,5,7-trimethyl-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-4,6-dione
- 8-(3-chlorostyryl)caffeine (CSC)
|
BDBM11020
 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase type B (MAO-B) Mutant (I199F)
| - 1,4-diphenyl-2-butene (DPB)
- [(2E)-4-phenylbut-2-en-1-yl]benzene
|
BDBM110983
 | 0 | 7 | 0 | 2 | 0 | 0 | 0 | 0 | - Serine/threonine-protein kinase/endoribonuclease IRE1 Alpha
| - US8614253, 3-14
- US8614253, 42-12
- US8614253, 43-5
- US9241942, 3-14
- US9963434, Compound 3-14
|
BDBM111036
 | 0 | 8 | 0 | 1 | 0 | 0 | 0 | 0 | - Serine/threonine-protein kinase/endoribonuclease IRE1 Alpha
| - US8614253, 3-67
- US8614253, 3-74
- US8614253, 43-83
- US9241942, 3-67
- US9963434, Compound 3-74
|
BDBM11160
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Dipeptidyl peptidase 2 (DPP II)
- Dipeptidyl peptidase 4
- Dipeptidyl peptidase 9
- Dipeptidyl peptidase VIII
| - (3R)-3-amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]butan-1-one hydrochloride
- Sitagliptin Analog 13
- Triazolopiperazine Analogue 25
|
BDBM113577
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
- Disintegrin and metalloproteinase domain-containing protein 17
- Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Stromelysin-1
| - US8633196, 14
- US8633196, 5
- US9365529, 5
|
BDBM11365
 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Aldehyde dehydrogenase 1A1
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - CHEMBL98328
- Hydroxysulfonamide 46
- N-hydroxymethanesulfonamide
|
BDBM11372
 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Aldehyde dehydrogenase 1A1
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase-9
- Neutrophil collagenase
| - CHEMBL55310
- Hydroxysulfonamide 53
- N-hydroxybenzenesulfonamide
|
BDBM116235
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Beta-secretase 2
- IDH1 R132H
| - US10035794, Example 10
- US10683287, Example 10
- US8637508, 10
|
BDBM118313
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
| |
BDBM119122
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - MurA (E. coli)
- MurB (E. coli)
- MurB (S. aureus)
- MurC
- MurC (S. aureus)
- MurD
- MurD (S. aureus)
- MurE
- MurE (E. coli)
| - MurA/B/C/D/E inhibitor (compound 67)
|
BDBM120076
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 3A
- Macrophage colony stimulating factor receptor
- Macrophage colony-stimulating factor 1 receptor (c-Fms)
- Mast/stem cell growth factor receptor Kit
- Potassium voltage-gated channel subfamily H member 2
| - CHEMBL256712
- US8697716, 16
|
BDBM120395
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Mast/stem cell growth factor receptor Kit
- Platelet-derived growth factor receptor beta
- Tyrosine-protein kinase ABL1
| - US8703771, 13
- US8703771, 14
- US8703771, 8
|
BDBM120777
 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
| |
BDBM121388
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Aurora kinase A/Targeting protein for Xklp2
- Aurora kinase B
- Cytochrome P450 3A
- Macrophage colony stimulating factor receptor
- Mast/stem cell growth factor receptor Kit
- Tyrosine-protein kinase receptor FLT3
- Vascular endothelial growth factor receptor 1
- Vascular endothelial growth factor receptor 2
| |
BDBM121389
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Aurora kinase A/Targeting protein for Xklp2
- Aurora kinase B
- Cytochrome P450 3A
- Macrophage colony stimulating factor receptor
- Mast/stem cell growth factor receptor Kit
- Tyrosine-protein kinase receptor FLT3
- Vascular endothelial growth factor receptor 1
- Vascular endothelial growth factor receptor 2
| |
BDBM121390
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Aurora kinase A/Targeting protein for Xklp2
- Aurora kinase B
- Cytochrome P450 3A
- Macrophage colony stimulating factor receptor
- Mast/stem cell growth factor receptor Kit
- Tyrosine-protein kinase receptor FLT3
- Vascular endothelial growth factor receptor 1
- Vascular endothelial growth factor receptor 2
| |
BDBM123510
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- G-protein coupled receptor 4
- G-protein coupled receptor 4 (GPR4)
- Histamine H3 receptor
- Ovarian cancer G-protein coupled receptor 1
- Psychosine receptor
| |
BDBM123515
 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- G-protein coupled receptor 4
- G-protein coupled receptor 4 (GPR4)
- Histamine H3 receptor
- Melanin-concentrating hormone receptor 2/HERG
| |
BDBM123744
 | 0 | 7 | 0 | 2 | 0 | 0 | 0 | 0 | - Phospholipase D (PLD)
- Phospholipase D (PLD_sp)
- Phospholipase D2 (PLD2)
| - 5-Fluoro-N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-1H-indole-2-carboxamide, 14
- CHEMBL398567
- FIPI hydrochloride hydrate (FIPI_HCl)
|
BDBM123747
 | 0 | 9 | 0 | 0 | 0 | 0 |